» Articles » PMID: 39385008

A Circularly Permuted CasRx Platform for Efficient, Site-specific RNA Editing

Abstract

Inactive Cas13 orthologs have been fused to a mutant human ADAR2 deaminase domain at the C terminus to enable programmable adenosine-to-inosine (A-to-I) RNA editing in selected transcripts. Although promising, existing RNA-editing tools generally suffer from a trade-off between efficacy and specificity, and off-target editing remains an unsolved problem. Here we describe the development of an optimized RNA-editing platform by rational protein engineering, CasRx-based Programmable Editing of RNA Technology (xPERT). We demonstrate that the topological rearrangement of a CasRx K940L mutant by circular permutation results in a robust scaffold for the tethering of a deaminase domain. We benchmark our tool against the REPAIR system and show that xPERT exhibits strong on-target activity like REPAIRv1 but low off-target editing like REPAIRv2. Our xPERT platform can be used to alter RNA sequence information without risking genome damage, effect temporary cellular changes and customize protein function.

Citing Articles

Paraxial mesoderm as a direct gateway to lymphatic endothelial cells.

Petrova T, Orlova V Nat Cardiovasc Res. 2025; 4(1):11-12.

PMID: 39747452 DOI: 10.1038/s44161-024-00583-0.

References
1.
Cox D, Platt R, Zhang F . Therapeutic genome editing: prospects and challenges. Nat Med. 2015; 21(2):121-31. PMC: 4492683. DOI: 10.1038/nm.3793. View

2.
Ihry R, Worringer K, Salick M, Frias E, Ho D, Theriault K . p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells. Nat Med. 2018; 24(7):939-946. DOI: 10.1038/s41591-018-0050-6. View

3.
Haapaniemi E, Botla S, Persson J, Schmierer B, Taipale J . CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat Med. 2018; 24(7):927-930. DOI: 10.1038/s41591-018-0049-z. View

4.
Nishikura K . A-to-I editing of coding and non-coding RNAs by ADARs. Nat Rev Mol Cell Biol. 2015; 17(2):83-96. PMC: 4824625. DOI: 10.1038/nrm.2015.4. View

5.
Merkle T, Merz S, Reautschnig P, Blaha A, Li Q, Vogel P . Precise RNA editing by recruiting endogenous ADARs with antisense oligonucleotides. Nat Biotechnol. 2019; 37(2):133-138. DOI: 10.1038/s41587-019-0013-6. View